UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

CORRECTION OF PSYCHO-EMOTIONAL DISORDERS IN PATIENTS WITH COVID-19

Type of Article

In the Section

Abstract

Pages

Bibliography

1. To KK, Sridhar S, Chiu KH, Hung DL, Li X, Hung IF, Tam AR,Chung TW, Chan JF, Zhang AJ, Cheng VC, Yuen KY. Lessonslearned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg Microbes Infect. 2021 Dec;10(1):507-535. doi: 10.1080/22221751.2021.1898291. PMID: 33666147;PMCID: PMC8006950.
2. Mishchenko, T. S., & Mishchenko, V. M. (2021). Неврологічніускладнення у пацієнтів з COVID-19 // Психіатрія, неврологіята медична психологія [Neurological complications in patientswith COVID-19]. [Psychiatry, neurology and medical psychology],(16). 23-33. https://doi.org/10.26565/2312-5675-2021-16-03.(In Ukrainian).
3. Caronna E, van den Hoek TC, Bolay H, Garcia-Azorin D,Gago-Veiga AB, Valeriani M, Takizawa T, Messlinger K, Shapiro  RE, Goadsby PJ, Ashina M, Tassorelli C, Diener HC, Terwindt GM, Pozo-Rosich P. Headache attributed to SARS-CoV-2infection, vaccination and the impact on primary headachedisorders of the COVID-19 pandemic: A comprehensive review. Cephalalgia. 2023 Jan;43(1):3331024221131337. doi:10.1177/03331024221131337. PMID: 36606562.
4. Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E. Neurological manifestations associated with SARS-CoV-2and other coronaviruses: A  narrative review for clinicians.Rev Neurol (Paris). 2021 Jan-Feb;177(1-2):51-64. doi: 10.1016/j.neurol.2020.10.001. Epub 2020 Dec 16. PMID: 33446327; PMCID:PMC7832485.
5. Jafari Z, Kolb BE, Mohajerani MH. Hearing Loss, Tinnitus, and Dizziness in  COVID-19: A  Systematic Review andMeta-Analysis. Can J Neurol Sci. 2022 Mar;49(2):184-195. doi:10.1017/cjn.2021.63. Epub 2021 Apr 12. PMID: 33843530; PMCID:PMC8267343.
6. Narożny W, Tretiakow D, Skorek A. Czy wirus SARS-CoV-2może uszkadzać słuch i  równowagę? [Can  the SARS-CoV-2virus damage human hearing and balance?]. Med  Pr. 2021Jun 30;72(3):321-325. Polish. doi: 10.13075/mp.5893.01083.Epub 2021 Apr 2. PMID: 33835112.
7. Panariello F., Cellini L., Speciani M., De Ronchi D., Atti A.R.How  Does SARS-CoV-2 Affect the Central Nervous System?A Working Hypothesis. Front Psychiatry. 2020. 11. 582345. Published 2020 Nov 16. doi: 10.3389/fpsyt.2020.582345.
8. Troyer EA, Kohn JN, Hong S. Are we facing a crashing waveof neuropsychiatric sequelae of COVID-19? Neuropsychiatricsymptoms and potential immunologic mechanisms. Brain BehavImmun. 2020 Jul;87:34-39. doi: 10.1016/j.bbi.2020.04.027. Epub2020 Apr 13. PMID: 32298803; PMCID: PMC7152874.
9. Vindegaard N, Benros ME. COVID-19 pandemic andmental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020 Oct;89:531-542. doi:10.1016/j.bbi.2020.05.048. Epub 2020 May 30. PMID: 32485289;PMCID: PMC7260522.
10. Weir К. How COVID-19 attacks the brain. Monitoron Psychology. 2020. Vol. 51. No.  8. 20  p. https://www.apa.org/monitor/2020/11/attacks-brain.
11. Garg RK. Spectrum of Neurological Manifestations in Covid-19: A Review. Neurol India. 2020 May-Jun;68(3):560-572. doi:10.4103/0028-3886.289000. PMID: 32643664.
12. Hu Y, Chen Y, Zheng Y, You C, Tan J, Hu L, Zhang Z, Ding L.Factors related to mental health of inpatients with COVID-19in Wuhan, China. Brain Behav Immun. 2020 Oct;89:587-593. doi:10.1016/j.bbi.2020.07.016. Epub 2020 Jul 15. PMID: 32681866;PMCID: PMC7362867.
13. Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E,Bourbao-Tournois C, Laribi S, Flament T, Ferreira-Maldent N,Bruyère F, Stefic K, Gaudy-Graffin C, Grammatico-Guillon  L,Bernard L. Follow-up  of  adults with noncritical COVID-19two months after symptom onset. Clin. Microbiol. Infect. 2021Feb;27(2):258-263. doi: 10.1016/j.cmi.2020.09.052. Epub 2020Oct 5. PMID: 33031948; PMCID: PMC7534895.
14. Зозуля І. С., Мардзвік В. М., Мардзвік М. В. Судинніневрологічні ускладнення в пацієнтів з COVID-19 // Український медичний часопис. / Zozulia  I.  S., Mardzvik V.  M.,Mardzvik M. V. [Vascular neurological complications in patients with COVID-19]. Ukrainskyi medychnyi chasopys [Ukrainianmedical journal]. 2021. ІІ/IV. 2(142). DOI: 10.32471/umj.1680-3051.142.204731. (In Ukrainian).
15. Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, Melloni EMT, Furlan R, Ciceri F, Rovere-Querini P; COVID-19BioB Outpatient Clinic Study group; Benedetti F. Anxiety anddepression in COVID-19 survivors: Role of inflammatory andclinical predictors. Brain Behav Immun. 2020 Oct;89:594-600. doi:10.1016/j.bbi.2020.07.037. Epub 2020 Jul 30. PMID: 32738287;PMCID: PMC7390748.
16. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. More than 50 Longterm effects of COVID-19: a systematic review and meta-analysis.Sci Rep. 2021 Aug 9;11(1):16144. doi: 10.1038/s41598-021-95565-8. PMID: 34373540; PMCID: PMC8352980.
17. Копчак О.  О.  Особливості когнітивних порушеньпри  COVID-19  // Міжнародний неврологічний журнал.2021. Т. 17. № 3. С. 12. / Kopchak O. O. [Peculiarities of cognitive disorders in COVID-19. [International Journal of Neurology]. DOI: http://dx.doi.org/ https://doi.org/10.22141/2224-0713.17.3.2021.231569. (In Ukrainian).
18. Fartushna, O., Palahuta, H., & Yevtushenko, S. Neurologicaland neuropsychiatric manifestations and complications of SARSCoV-2 infection: a narrative review and a case presentation in a previously healthy young white adult. Міжнародний неврологічнийжурнал [International Neurological Journal]. (2021). 17(1), 17–22.DOI: https://doi.org/10.22141/2224-0713.17.1.2021.226914.